JournalCurrent Protocols in Microbiology
PublisherBlackwell Publishing Inc.
MetadataShow full item record
AbstractMiddle East respiratory syndrome coronavirus (MERS-CoV) is an emerging highly pathogenic respiratory virus. Although MERS-CoV only emerged in 2012, we and others have developed assays to grow and quantify infectious MERS-CoV and RNA products of replication in vitro. MERS-CoV is able to infect a range of cell types, but replicates to high titers in Vero E6 cells. Protocols for the propagation and quantification of MERS-CoV are presented.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84949220116&doi=10.1002%2f9780471729259.mc15e02s37&partnerID=40&md5=6f2999f2d1fafd854c3a3f11c62a3253; http://hdl.handle.net/10713/12410